TEVA 7390 (Risedronate Sodium 5 mg)
Pill with imprint TEVA 7390 is Yellow, Round and has been identified as Risedronate Sodium 5 mg. It is supplied by Teva Pharmaceuticals USA Inc.
Risedronate is used in the treatment of prevention of osteoporosis; osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEVA 7390
Risedronate Sodium
- Imprint
- TEVA 7390
- Strength
- 5 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Bisphosphonates
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA Inc.
- National Drug Code (NDC)
- 00093-3099
- Inactive Ingredients
-
silicon dioxide,
corn starch,
hypromellose 2910 (3 mPa.s),
hypromellose 2910 (5 mPa.s),
lactose monohydrate,
magnesium stearate,
polyethylene glycol 400,
sodium stearyl fumarate,
titanium dioxide,
D&C Yellow No. 10,
ferric oxide yellow,
polysorbate 80
Note: Inactive ingredients may vary.
More about risedronate
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (65)
- Patient tips
- Drug images
- Pricing & coupons
- En español
- Drug class: bisphosphonates
Patient resources
- Drug Information
- Risedronate (Advanced Reading)
- Risedronate Delayed-Release Tablets
- Risedronate Tablets
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.